Hakim Bouterfa
Impact in
Papers in
- Epidemiology 13
- Neuroendocrine Tumor Research Advances 12
-
- Neuroblastoma Research and Treatments 6
- Co-authors
- Klaus Roosen (10 shared papers)Detlef Doenecke (7 shared papers)Joerg Tonn (6 shared papers)François Jamar (3 shared papers)Larry K. Kvols (3 shared papers)Raffaella Barone (3 shared papers)Roelf Valkema (2 shared papers)Eric P. Krenning (2 shared papers)
- Journals
- Journal of Nuclear Medicine (3 papers)Neurosurgery (2 papers)Clinical Endocrinology (2 papers)Journal of Neuro-Oncology (2 papers)European Journal of Biochemistry (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Hakim Bouterfa
36 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 96
- Neurology 594
- Oncology 890
- Epidemiology 1.1k
- Endocrinology, Diabetes and Metabolism 387
- Radiology, Nuclear Medicine and Imaging 445
Countries citing papers authored by Hakim Bouterfa
This map shows the geographic impact of Hakim Bouterfa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakim Bouterfa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakim Bouterfa more than expected).
Fields of papers citing papers by Hakim Bouterfa
This network shows the impact of papers produced by Hakim Bouterfa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakim Bouterfa. The network helps show where Hakim Bouterfa may publish in the future.
Co-authors
The 25 scholars most cited alongside Hakim Bouterfa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 250 | |
| 2 | 2010 | 248 | |
| 3 | 2003 | 201 | |
| 4 | 2007 | 172 | |
| 5 | 2017 | 141 | |
| 6 | 1999 | 132 | |
| 7 | 2017 | 124 | |
| 8 | Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. | 2000 | 119 |
| 9 | 2004 | 117 | |
| 10 | 2005 | 109 | |
| 11 | 2008 | 96 | |
| 12 | 1988 | 83 | |
| 13 | 2017 | 77 | |
| 14 | 1994 | 74 | |
| 15 | 2000 | 74 | |
| 16 | Evaluating the clinical effectiveness of 90Y-SMT 487 in patients with neuroendocrine tumors. | 2003 | 55 |
| 17 | 2004 | 46 | |
| 18 | Potential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferons. | 1996 | 46 |
| 19 | 1999 | 43 | |
| 20 | 1995 | 41 |
About Hakim Bouterfa
Hakim Bouterfa is a scholar working on Epidemiology, Neurology, Oncology, Endocrinology, Diabetes and Metabolism and Immunology and Allergy, having authored 36 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (12 papers), Neuroblastoma Research and Treatments (6 papers), Lung Cancer Research Studies (5 papers), Retinoids in leukemia and cellular processes (4 papers), Estrogen and related hormone effects (3 papers), Genomics and Chromatin Dynamics (3 papers), Epigenetics and DNA Methylation (3 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Neurology (594 citations), Oncology (890 citations), Epidemiology (1.1k citations), Endocrinology, Diabetes and Metabolism (387 citations) and Radiology, Nuclear Medicine and Imaging (445 citations). Hakim Bouterfa has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Klaus Roosen, Detlef Doenecke, Joerg Tonn, François Jamar, Larry K. Kvols, Raffaella Barone, Roelf Valkema, Eric P. Krenning, Jens Kaufmann and Guillaume Nicolas. Their work appears in journals such as Journal of Nuclear Medicine, Neurosurgery, Clinical Endocrinology, Journal of Neuro-Oncology and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.